Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isa Mambetsariev

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
Iscience|November 2, 2020
Erratum: A Non-genetic Mechanism Involving the Integrin β4/Paxillin Axis Contributes to Chemoresistance in Lung CancerAtish Mohanty, Arin Nam, Alex Pozhitkov, et al.
Cell Reports. Medicine|June 16, 2026
The IMMUNO-BIOMAP trial in NSCLC: An adaptive multimodal framework for biomarker-guided careAritro Nath, Jyoti Malhotra, Isa Mambetsariev, et al.
Iscience|July 12, 2024
Teriflunomide/leflunomide synergize with chemotherapeutics by decreasing mitochondrial fragmentation via DRP1 in SCLCTamara Mirzapoiazova, Liz Tseng, Bolot Mambetsariev, et al.
Molecular Cancer Therapeutics|July 13, 2021
Protein Phosphatase 2A as a Therapeutic Target in Small Cell Lung CancerTamara Mirzapoiazova, Gang Xiao, Bolot Mambetsariev, et al.
Plos One|February 12, 2020
Precision medicine and actionable alterations in lung cancer: A single institution experienceIsa Mambetsariev, Yingyu Wang, Chen Chen, et al.
Molecular Cancer Therapeutics|April 4, 2022
Correction: Protein Phosphatase 2A as a Therapeutic Target in Small Cell Lung CancerTamara Mirzapoiazova, Gang Xiao, Bolot Mambetsariev, et al.
Cancers|July 2, 2021
Evaluation of Somatic Mutations in Solid Metastatic Pan-Cancer PatientsMoom R Roosan, Isa Mambetsariev, Rebecca Pharaon, et al.
Science Advances|October 13, 2023
Acquired resistance to KRAS G12C small-molecule inhibitors via genetic/nongenetic mechanisms in lung cancerAtish Mohanty, Arin Nam, Saumya Srivastava, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Iscience|November 2, 2020
Erratum: A Non-genetic Mechanism Involving the Integrin β4/Paxillin Axis Contributes to Chemoresistance in Lung CancerAtish Mohanty, Arin Nam, Alex Pozhitkov, et al.
Cell Reports. Medicine|June 16, 2026
The IMMUNO-BIOMAP trial in NSCLC: An adaptive multimodal framework for biomarker-guided careAritro Nath, Jyoti Malhotra, Isa Mambetsariev, et al.
Iscience|July 12, 2024
Teriflunomide/leflunomide synergize with chemotherapeutics by decreasing mitochondrial fragmentation via DRP1 in SCLCTamara Mirzapoiazova, Liz Tseng, Bolot Mambetsariev, et al.
Molecular Cancer Therapeutics|July 13, 2021
Protein Phosphatase 2A as a Therapeutic Target in Small Cell Lung CancerTamara Mirzapoiazova, Gang Xiao, Bolot Mambetsariev, et al.
Plos One|February 12, 2020
Precision medicine and actionable alterations in lung cancer: A single institution experienceIsa Mambetsariev, Yingyu Wang, Chen Chen, et al.
Molecular Cancer Therapeutics|April 4, 2022
Correction: Protein Phosphatase 2A as a Therapeutic Target in Small Cell Lung CancerTamara Mirzapoiazova, Gang Xiao, Bolot Mambetsariev, et al.
Cancers|July 2, 2021
Evaluation of Somatic Mutations in Solid Metastatic Pan-Cancer PatientsMoom R Roosan, Isa Mambetsariev, Rebecca Pharaon, et al.
Science Advances|October 13, 2023
Acquired resistance to KRAS G12C small-molecule inhibitors via genetic/nongenetic mechanisms in lung cancerAtish Mohanty, Arin Nam, Saumya Srivastava, et al.
Pageof 8